This case emphasizes the significance of anti-IgLON5 encephalitis in the differential diagnosis of complex sleep disorders, while also providing new insights and experiences regarding the evaluation of immune-modulatory therapy in the treatment of anti-IgLON5 encephalitis through 18F-FDG PET-CT. This evidence concerns the gene IGLON5 and sleep disorder.